Your browser doesn't support javascript.
loading
Natural Allies for Heart Health: Nrf2 Activation and Cardiovascular Disease Management.
Khan, Safir Ullah; Khan, Shahid Ullah; Suleman, Muhammad; Khan, Munir Ullah; Khan, Muhammad Sirab; Arbi, Fawad Mueen; Hussain, Talib; Mohammed Alsuhaibani, Amnah; S Refat, Moamen.
Afiliação
  • Khan SU; Hefei National Laboratory for Physical Sciences at the Microscale, School of Life Sciences, University of Science and Technology of China, Hefei, China.
  • Khan SU; Integrative Science Center of Germplasm Creation in Western China (CHONGQING) Science City and South west University, College of Agronomy and Biotechnology, Southwest University, Chongqing, China; Department of Biochemistry, Women Medical and Dental College, Khyber Medical University, Abbottabad, Kh
  • Suleman M; Center for Biotechnology and Microbiology, University of Swat, Swat, Pakistan; Laboratory of Animal Research Center (LARC), Qatar University, Doha, Qatar.
  • Khan MU; MOE Key Laboratory of Macromolecular Synthesis and Functionalization, International Research Center for X Polymers, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, China.
  • Khan MS; Department of Botany, University of Science and Technology, Bannu, Pakistan.
  • Arbi FM; Quaid-e-Azam Medical College, Bahawalpur, Punjab, Pakistan.
  • Hussain T; Women Dental College Abbottabad, Khyber Pakhtunkhwa, Pakistan.
  • Mohammed Alsuhaibani A; Department of Physical Sport Science, College of Education, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
  • S Refat M; Department of Chemistry, College of Science, Taif University, Taif, Saudi Arabia.
Curr Probl Cardiol ; 49(1 Pt B): 102084, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37714318
ABSTRACT
The term "cardiovascular diseases" (CVD) refers to various ailments that affect the heart and blood vessels, including myocardial ischemia, congenital heart defects, heart failure, rheumatic heart disease, hypertension, peripheral artery disease, atherosclerosis, and cardiomyopathies. Despite significant breakthroughs in preventative measures and treatment choices, CVDs significantly contribute to morbidity and mortality, imposing a considerable financial burden. Oxidative stress (OS) is a fundamental contributor to the development and progression of CVDs, resulting from an inherent disparity in generating reactive oxygen species. The disparity above significantly contributes to the aberrant operation of the cardiovascular system. To tackle this issue, therapeutic intervention primarily emphasizes the nuclear erythroid 2-related factor 2 (Nrf2), a transcription factor crucial in regulating endogenous antioxidant defense systems against OS. The Nrf2 exhibits potential as a promising target for effectively managing CVDs. Significantly, an emerging field of study is around the utilization of natural substances to stimulate the activation of Nrf2, hence facilitating the promotion of cardioprotection. This technique introduces a new pathway for treating CVD. The substances above elicit their advantageous effects by mitigating the impact of OS via initiating Nrf2 signaling. The primary objective of our study is to provide significant insights that can contribute to advancing treatment methods, including natural products. These strategies aim to tackle the obstacles associated with CVDs.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares Limite: Humans Idioma: En Revista: Curr Probl Cardiol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares Limite: Humans Idioma: En Revista: Curr Probl Cardiol Ano de publicação: 2024 Tipo de documento: Article